TipRanks
Biosergen AB (SE:BIOSGN)
:BIOSGN
Sweden Market
Want to see SE:BIOSGN full AI Analyst Report?

Biosergen AB (BIOSGN) Drug Pipeline

0 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Bsg005
Invasive Fungal Infection
Phase I/II
Recruiting
Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection
Aug 29, 2024
―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Biosergen AB (BIOSGN) have in its pipeline
      BIOSGN is currently developing the following drugs: Bsg005. These drug candidates are in various stages of clinical development as the company works toward FDA approval.